| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Gsk Plc (GSK) has 1 insider with recent SEC Form 4 filings, including 4 buys and 1 sell. GSK is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 18.25M | $928.25M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 11, 2025 | Gsk Plc | 10% Owner | Buy | 1,470,000 | $19.00 | $27,930,000.00 | +8.8% | +12.8% | - | |
| Sep 27, 2024 | Gsk Plc | 10% Owner | Buy | 2,791,930 | $8.00 | $22,335,440.00 | +20.0% | -16.2% | -2.1% | |
| Dec 7, 2023 | Gsk Plc | 10% Owner | Buy | 3,300,000 | $5.00 | $16,500,000.00 | +30.9% | +18.4% | -4.0% | |
| Jul 2, 2021 | Glaxosmithkline Plc | 10% Owner | Buy | 275,000 | $18.00 | $4,950,000.00 | +37.5% | -4.3% | +11.8% | |
| May 20, 2021 | Glaxosmithkline Plc | 10% Owner | Sell | 32,005,260 | $12.25 | $392,064,435.00 | -100% | +8.0% | +17.8% |